HomeCompareTBPMF vs ORCC

TBPMF vs ORCC: Dividend Comparison 2026

TBPMF yields 222222.22% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBPMF wins by $1.4076447531278624e+30M in total portfolio value
10 years
TBPMF
TBPMF
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076447531278624e+30M
Annual income
$1,406,399,782,569,334,400,000,000,000,000,000,000.00
Full TBPMF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — TBPMF vs ORCC

📍 TBPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBPMFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBPMF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBPMF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBPMF
Annual income on $10K today (after 15% tax)
$18,888,888.89/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, TBPMF beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBPMF + ORCC for your $10,000?

TBPMF: 50%ORCC: 50%
100% ORCC50/50100% TBPMF
Portfolio after 10yr
$7.038223765639312e+29M
Annual income
$703,199,891,284,667,200,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

TBPMF
No analyst data
Altman Z
-75.5
Piotroski
2/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBPMF buys
0
ORCC buys
0
No recent congressional trades found for TBPMF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBPMFORCC
Forward yield222222.22%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$1.4076447531278624e+30M$21.4K
Annual income after 10y$1,406,399,782,569,334,400,000,000,000,000,000,000.00$1.04
Total dividends collected$1.4075632434891558e+30M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: TBPMF vs ORCC ($10,000, DRIP)

YearTBPMF PortfolioTBPMF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$22,232,922$22,222,222.22$11,190$489.61+$22.22MTBPMF
2$46,198,082,523$46,174,293,296.41$12,229$256.01+$46198.07MTBPMF
3$89,718,752,943,223$89,669,320,994,923.30$13,216$130.74+$89718752.93MTBPMF
4$162,845,393,609,755,680$162,749,394,544,106,430.00$14,207$66.02+$162845393609.74MTBPMF
5$276,249,735,879,778,500,000$276,075,491,308,616,120,000.00$15,234$33.17+$276249735879778.50MTBPMF
6$437,989,462,258,048,500,000,000$437,693,875,040,657,100,000,000.00$16,317$16.62+$437989462258048512.00MTBPMF
7$649,026,142,700,674,900,000,000,000$648,557,493,976,058,700,000,000,000.00$17,468$8.32+$649026142700674875392.00MTBPMF
8$898,874,153,179,794,200,000,000,000,000$898,179,695,207,104,400,000,000,000,000.00$18,695$4.16+$8.988741531797941e+23MTBPMF
9$1,163,523,886,474,633,300,000,000,000,000,000$1,162,562,091,130,731,000,000,000,000,000,000.00$20,006$2.08+$1.1635238864746333e+27MTBPMF
10$1,407,644,753,127,862,300,000,000,000,000,000,000$1,406,399,782,569,334,400,000,000,000,000,000,000.00$21,407$1.04+$1.4076447531278624e+30MTBPMF

TBPMF vs ORCC: Complete Analysis 2026

TBPMFStock

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.

Full TBPMF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this TBPMF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBPMF vs SCHDTBPMF vs JEPITBPMF vs OTBPMF vs KOTBPMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.